Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Govardhan M Dhoot has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE:23-02-2012
23-02-2012
Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Goverdhan M Dhoot has submitted the disclosure under Regulation 13(4), 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:21-02-2012
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mangalam Drugs & Organics Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:21-02-2012
Financial Results & Limited Review for Dec 31, 2011
Mangalam Drugs & Organics Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2011.13-02-2012
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Shree Kishoriju Trading & Investment Pvt Ltd & Shree Rasbihari Trading & Investment Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Mangalam Drugs & Organics LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Shree Kishoriju Trading & Investment Pvt Ltd & Shree Rasbihari Trading & Investment Pvt Ltd...27-12-2011
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Goverdhan Murlidhar Dhoot , Brijmohan Murlidhar Dhoot & Rekha Goverdhan Dhoot has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Mangalam Drugs & Organics LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Goverdhan Murlidhar Dhoot , Brijmohan Murlidhar Dhoot & Rekha Goverdhan Dhoot...27-12-2011
Financial Results for Sep 30, 2011
Mangalam Drugs & Organics Ltd has informed BSE about the Financial Results for the period ended September 30, 2011.10-11-2011
Outcome of AGM
Mangalam Drugs & Organics Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on September 29, 2011, inter alia, have passed the following:1. Consideration and Adoption of the Audited Balance Sheet as at March 31, 2011, Profit and Loss Account for the year ended on that date and the reports of Board of Directors and Auditors thereon....10-10-2011
Change in the Venue of AGM
Mangalam Drugs & Organics Ltd has informed BSE that due to unavoidable circumstances, the Annual General Meeting (AGM) of the Company convened to be held at the registered office of the Company, 292 Princess Street, 2nd Floor, Near Flyover, Marine Lines, Mumbai - 400 002 on September 29, 2011 at 3.00 PM vide Companys notice letter September 30, 2011 now will be held at C/o. IMP Powers Ltd., 35C Popular Press Building, 2nd Floor, Pt. M. M. Malviya...22-09-2011
AGM on Sep 29, 2011
Mangalam Drugs & Organics Ltd has informed BSE that the 38th Annual General Meeting (AGM) of the Company will be held on September 29, 2011, at the Registered Office of the Company at 292, Princess Street, 2nd Floor, Near Flyover, Marine Lines, Mumbai-400002 at 3.00 p.m.07-09-2011